Subject: Re: Coloplast
Scratch that - $15-$20 in 1 year is a stupid target. I would expect earnings to be up 25-35% and for dividends to increase as typical. With no change in valuation multiples since it already has a historically low but still elevated PE ratio, target in a year might be more like $13-$15. But what I find really appealing about is that I expect it to be good diversification within a portfolio with a good amount of US stock exposure.